1 Min Read
Nov 9 (Reuters) - Pharmesis International Ltd
* Qtrly revenue RMB17.3 million versus RMB16.6 million
* Qtrly loss attributable to equity holders of company RMB198,000 versus loss of RMB279,000 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.